deaths from glp-1 Drugs Linked to Dramatically Lower Death Rates in Colon Cancer Patients Nurse's death linked to weight-loss

Use depends on context

Studies of pancreatic alpha cell function in normal and diabetic subjects

Participants receiving the highest dose demonstrated mean weight reductions of approximately 24% and significant improvements in HbA1c, with gastrointestinal side effects as the most common adverse events

This provision requires PBMs to report detailed prescription drug utilization and spending data to most employer health plans, including gross and net spending, out-of-pocket spending, pharmacy reimbursement, and other details related to the plans pharmacy benefit, effective for plan years beginning 30 months after the date of enactment